Biologics and Atorvastatin/Ezetimibe in patients with carotid atherosclerosis and Rheumatoid Arthritis (The BioAtoRA study) - an international, double-blind, randomised, placebo-controlled trial
- Prosjektnummer
- 2016063
- Ansvarlig person
- Anne Grete Semb
- Institusjon
- Diakonhjemmet Sykehus AS
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cardiovascular, Inflammatory and Immune System, Musculoskeletal
- Forskningsaktivitet
- 3. Prevention, 6. Treatment Evaluation
NEI
NEI
NEI
NEI
NEI
Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
Semin Arthritis Rheum 2021 10;51(5):1081-1088. Epub 2021 aug 20
PMID: 34450506
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit.
RMD Open 2021 07;7(2).
PMID: 34244381
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries.
Eur Heart J Cardiovasc Pharmacother 2021 Jul 07. Epub 2021 jul 7
PMID: 34232315
Degree of arterial stiffness is comparable across inflammatory joint disease entities.
Scand J Rheumatol 2021 Jun 16. Epub 2021 jun 16
PMID: 34132621
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment.
Eur Cardiol 2021 Feb;16():e18. Epub 2021 mai 13
PMID: 34040652
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.
Nat Rev Rheumatol 2020 07;16(7):361-379. Epub 2020 jun 3
PMID: 32494054
Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study.
Rheumatology (Oxford) 2020 12 01;59(12):3700-3708.
PMID: 32386421
Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age models.
Arthritis Res Ther 2020 04 23;22(1):90. Epub 2020 apr 23
PMID: 32326974
Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers.
Rheumatol Int 2020 Apr;40(4):523-527. Epub 2020 feb 22
PMID: 32088752
Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients.
Rheumatology (Oxford) 2020 08 01;59(8):1997-2004.
PMID: 31782789
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro
Ann Rheum Dis 2020 09;79(9):e105. Epub 2019 aug 14
PMID: 31413003
High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients.
Br J Sports Med 2020 Mar;54(5):292-297. Epub 2019 feb 11
PMID: 30745314
Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases.
Int J Cardiol 2019 Jan 01;274():311-318. Epub 2018 jul 2
PMID: 30007486
Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis.
Arthritis Care Res (Hoboken) 2019 Sep;71(9):1276-1283. Epub 2019 aug 7
PMID: 30242984
Biomarkers of cardiovascular risk across phenotypes of osteoarthritis.
BMC Rheumatol 2019;3():33. Epub 2019 aug 8
PMID: 31410391
Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.
Cochrane Database Syst Rev 2019 09 02;9():CD012958. Epub 2019 sep 2
PMID: 31476270
Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases.
PLoS One 2019;14(12):e0226479. Epub 2019 des 12
PMID: 31830762
Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
Ann Rheum Dis 2018 Jan;77(1):48-54. Epub 2017 sep 6
PMID: 28877868
Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases.
Int J Cardiol 2018 Feb 01;252():201-206.
PMID: 29249429
Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Trøndelag Health Study (HUNT).
RMD Open 2018;4(1):e000630. Epub 2018 mar 14
PMID: 29556420
Optimization of CVD prevention in psoriatic arthritis.
Nat Rev Rheumatol 2018 Jun;14(6):323-324.
PMID: 29686327
Ankylosing Spondylitis Is Associated with Increased Prevalence of Left Ventricular Hypertrophy.
J Rheumatol 2018 Aug;45(9):1249-1255. Epub 2018 jun 1
PMID: 29858235
The effect of brief versus individually tailored dietary advice on change in diet, lipids and blood pressure in patients with inflammatory joint disease.
Food Nutr Res 2018;62(). Epub 2018 sep 4
PMID: 30202399
Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project.
RMD Open 2018;4(2):e000737. Epub 2018 okt 1
PMID: 30305931
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Ann Rheum Dis 2017 Jan;76(1):17-28. Epub 2016 okt 3
PMID: 27697765
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
PLoS One 2017;12(3):e0174656. Epub 2017 mar 23
PMID: 28334012
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
Rheumatology (Oxford) 2017 07 01;56(7):1102-1110.
PMID: 28339992
Cardiovascular disease risk profiles in inflammatory joint disease entities.
Arthritis Res Ther 2017 Jul 03;19(1):153. Epub 2017 jul 3
PMID: 28673314
Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases.
RMD Open 2017;3(2):e000544. Epub 2017 sep 17
PMID: 28955501
The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.
Trials 2017 Nov 28;18(1):570. Epub 2017 nov 28
PMID: 29183347
Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.
Int J Cardiol 2016 Nov 15;223():331-336. Epub 2016 aug 7
PMID: 27543704
Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitis.
Nat Rev Rheumatol 2016 Aug;12(8):441-2. Epub 2016 jun 30
PMID: 27357255
Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.
J Rheumatol 2016 Sep;43(9):1622-30. Epub 2016 jun 15
PMID: 27307523
The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis.
Blood Press 2016 10;25(5):298-304. Epub 2016 apr 28
PMID: 27123584
Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.
PLoS One 2016;11(4):e0153440. Epub 2016 apr 19
PMID: 27093159
Chronic kidney disease reduces risk of cardiovascular disease in patients with rheumatoid arthritis according to the QRISK lifetime cardiovascular risk calculator.
Rheumatology (Oxford) 2016 Aug;55(8):1528-9. Epub 2016 feb 8
PMID: 26857077
On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.
Ann Rheum Dis 2016 May;75(5):819-24. Epub 2015 mar 26
PMID: 25814652
Effekten av kolesterolvennlig kostholdsråd på endring i kosthold og kardiovaskulære risikofaktorer hos pasienter med leddsykdom
Ernæringsfysiologisk mastergrad, Ernæringsfysilogisk Institutt, Universitet i Oslo, November 2016 Hovedveileder: AG Semb, Biveiledere: S Rollefstad, SU Olsen, K Holven
Cardiovascular diseae risk evaluation
p 53-71 in Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis. Ed. Semb AGSpringer International Publishing Switzerland. ISBN 978-3-319-26780-7, ISBN 978-3-319-26782-1 (eBook), DOI 10.1007/978-3-319-26782-1
Pharmacological management of cardiovascular disease in patients with rheumatoid arthritis
p 73-92 in Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis. Ed. Semb AGSpringer International Publishing Switzerland. ISBN 978-3-319-26780-7, ISBN 978-3-319-26782-1 (eBook), DOI 10.1007/978-3-319-26782-1
Conclusion
p 107-109 in Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis. Ed. Semb AGSpringer International Publishing Switzerland. ISBN 978-3-319-26780-7, ISBN 978-3-319-26782-1 (eBook), DOI 10.1007/978-3-319-26782-1
Cardiovascular disease risk in inflammatory joint disease
- Disputert:
- februar 2019
- Hovedveileder:
- Anne Grete Semb
Markers of Progression and Regression of Atherosclerotic Cardiovascular Disease in Patients with Inflammatory Joint Diseases
- Disputert:
- mai 2017
- Hovedveileder:
- Anne Grete Semb, biveileder: S Rollefstad
- Anne Mirjam Kerola Forsker (annen finansiering)
- Arthur Kavanaugh Forsker (annen finansiering)
- Inger Jorid Berg Forsker (annen finansiering)
- Sella Aarrestad Provan Forsker (annen finansiering)
- Silvia Christin Hellerud Rollefstad Postdoktorstipendiat (finansiert av denne bevilgning)
- Anne Grete Semb Prosjektleder
- Glenn Haugeberg Forsker (annen finansiering)
- Grunde Wibetoe Doktorgradsstipendiat (annen finansiering)
- Eirik Ikdahl Prosjektdeltaker
- Mona Svanteson Doktorgradsstipendiat (annen finansiering)
- Hilde Berner Hammer Forsker (annen finansiering)
- Silje Halvorsen Sveaas Forsker (annen finansiering)
- Tillmann Uhlig Forsker (annen finansiering)
- Tore Kristian Kvien Forsker (annen finansiering)
- Nils Einar Kløw Forsker (annen finansiering)
- Ingrid Ylva Natasha Haig Forsker (annen finansiering)
- Eva Gerdts Forsker (annen finansiering)
- Helga Bergljot Midtbø Forsker (annen finansiering)
- Nina Østerås Forsker (annen finansiering)
- Hanne Solveig Dagfinrud Forsker (annen finansiering)
- Agnete Malm Gulati Doktorgradsstipendiat (annen finansiering)
- Maria Grorud Fagerhøi Prosjektdeltaker
- Sissel Urke Olsen Doktorgradsstipendiat (annen finansiering)
- Ida Roelsgaard Doktorgradsstipendiat (annen finansiering)
- Mikkel Østergaard Forsker (annen finansiering)
- Bente Appel Esbensen Forsker (annen finansiering)
- Joe Sexton Prosjektdeltaker
- Inge Christoffer Olsen Prosjektdeltaker
- George Kitas Forsker (annen finansiering)
- Sherine Gabriel Forsker (annen finansiering)
- Piet van Riel Forsker (annen finansiering)
- Cynthia Sue Crowson Doktorgradsstipendiat (annen finansiering)
- Ian Graham Forsker (annen finansiering)
- Thalita Blanck Brukerrepresentant
- Olav Øverland Brukerrepresentant
- Jonny Hisdal Forsker (annen finansiering)
- Cynthia Crowson Forsker (annen finansiering)
- Mari Hoff Postdoktorstipendiat (annen finansiering)
- Ylva Haig Forsker (annen finansiering)
- Hanne Sofie Dagfinnrud Forsker (annen finansiering)
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport